Pathogenesis of Refractory SIBO and Oncological Risk in Hereditary Coproporphyria: The Catalytic Role of HFE-Mediated Iron Overload

Background: The diagnosis of autonomic dysfunction underlying Hereditary Coproporphyria (HCP) represents a major clinical challenge. Given the nonspecific and episodic nature of its crises, neurological and gastrointestinal symptoms are frequently misinterpreted and misdiagnosed as anxiety disorders or psychosomatic syndromes, severely delaying proper therapeutic management. Although HCP is characterized by the accumulation of porphyrin precursors, the high variability in tissue damage—ranging from refractory Small Intestinal Bacterial Overgrowth (SIBO) to inflammatory oncological processes (such as cholangiocarcinoma and cutaneous lymphomas)—suggests the necessity of an external catalyst. I postulate that abnormal iron metabolism is the primary driver of this pathological progression. Hypothesis: Iron overload mediated by the HFE mutation, combined with low ferroxidase activity (ceruloplasmin), generates an excess of non-transferrin-bound iron (NTBI) in the ferrous state (Fe2+). Furthermore, the high demand for heme synthesis driven by elevated hemoglobin forces the defective CPOX enzymatic pathway, massively increasing the accumulation of isomer III precursors. Free Fe2+ then acts as an oxidizing agent, transforming the inert coproporphyrinogen III into highly reactive and toxic coproporphyrin III. Mechanism: The oxidation of these isomers triggers systemic oxidative stress. Locally, oxidized porphyrins induce autonomic neuropathy in the myenteric plexus, paralyzing gastrointestinal motility and promoting intractable SIBO. Systemically, the massive biliary excretion of these reactive compounds causes chronic chemical inflammation in the bile ducts, increasing the risk of cholangiocarcinoma. Concurrently, cutaneous deposition of oxidized porphyrins generates chronic antigenic stimulation in the dermis, potentially acting as a trigger for lymphoproliferative neoplasms, such as marginal zone B-cell lymphoma. Clinical Relevance: This model suggests that patients with overlapping HFE and CPOX mutations face both autonomic dysfunction (SIBO) and elevated oncological risk due to chronic inflammation. Early management through therapeutic phlebotomies to reduce hemoglobin-driven heme demand and halt Fe2+-mediated oxidation, alongside intestinal binders, could prevent both neurogastrointestinal damage and long-term malignant transformation.